Literature DB >> 6465973

Gastric pseudolymphoma. A challenging clinical problem.

R K Orr, J R Lininger, W Lawrence.   

Abstract

Gastric pseudolymphoma is a benign inflammatory condition that is usually associated with chronic gastric ulcer and often mimics gastric carcinoma or malignant lymphoma. Our experience with 12 histologically documented gastric pseudolymphomas at the Medical College of Virginia is presented with an emphasis on the approach to both diagnosis and surgical management. Preoperative diagnoses in this series ranged from benign gastric ulcer to gastric cancer. Treatment was by gastric resection in all cases and it included, as a minimum, antrectomy and excision of the lesion with an adequate gross margin. Of 11 cases with adequate follow-up, there are eight asymptomatic patients without recurrence and one patient who died of other causes without recurrence 5 years after gastrectomy. One patient developed recurrent pseudolymphoma in the proximal gastric remnant 39 months after a distal subtotal gastrectomy for pseudolymphoma. Another patient subsequently developed Hodgkin's disease of the gastric remnant, with regional lymph node and liver involvement, and died 35 months after the earlier subtotal gastrectomy for pseudolymphoma. Our clinical experience with this confusing and uncommon entity is compared with that previously reported in the medical literature.

Entities:  

Mesh:

Year:  1984        PMID: 6465973      PMCID: PMC1250443          DOI: 10.1097/00000658-198408000-00012

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  33 in total

1.  Primary malignant lymphomas of the salivary glands.

Authors:  F A Nime; H S Cooper; J C Eggleston
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

2.  Gastric pseudolymphoma. A spectrum of presenting features and diagnostic considerations.

Authors:  R P Perrillo; F J Tedesco
Journal:  Am J Gastroenterol       Date:  1976-03       Impact factor: 10.864

3.  Gastric pseudolymphomas resembling angioproliferative lymph node hyperplasia.

Authors:  J Tóth; P Rónay
Journal:  Oncology       Date:  1974       Impact factor: 2.935

4.  Lymphoreticular hyperplasia of the stomach (pseudolymphoma).

Authors:  R S Nelson; F L Lanza; N G Bottiglieri
Journal:  Gastrointest Endosc       Date:  1973-05       Impact factor: 9.427

5.  Pseudolymphoma of the stomach.

Authors:  C J Wright
Journal:  Hum Pathol       Date:  1973-09       Impact factor: 3.466

6.  Pseudolymphoma of the stomach.

Authors:  R R Buchholz; R A Reid
Journal:  Surg Clin North Am       Date:  1972-04       Impact factor: 2.741

7.  Pseudolymphomas.

Authors:  R Robbins; A R Peale; T al-Saleem
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1970-01

8.  The radiographic manifestations of pseudolymphoma of the stomach.

Authors:  J T Chiles; C E Platz
Journal:  Radiology       Date:  1975-09       Impact factor: 11.105

9.  Malignant lymphomas of the thyroid: a clinical pathologic study of 35 patients including ultrastructural observations.

Authors:  J S Burke; J J Butler; L M Fuller
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

10.  Lymphoreticular hyperplasia of the stomach (pseudolymphoma).

Authors:  W Martel; M R Abell; T N Allan
Journal:  AJR Am J Roentgenol       Date:  1976-08       Impact factor: 3.959

View more
  4 in total

1.  Gastric "pseudolymphoma" with restricted light chain expression in a patient with obscure gastrointestinal blood loss.

Authors:  H Schulman; J Sickel; M S Kleinman; J T Adams
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

2.  Pseudolymphoma of the jejunum.

Authors:  H Gudjonsson; M Jones; E L Krawitt; M D Kaye
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

3.  Unique features of Helicobacter pylori disease in children.

Authors:  E Hassall; J E Dimmick
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

Review 4.  Endoscopic and histologic resolution of gastric pseudolymphoma (reactive lymphoid hyperplasia) following treatment with bismuth and oral antibiotics.

Authors:  A P Weston; D R Campbell; D H McGregor; R Cherian
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.